tiprankstipranks
Advertisement
Advertisement
Rhythm Biosciences expands ColoSTAT access program as clinician uptake grows
PremiumCompany AnnouncementsRhythm Biosciences expands ColoSTAT access program as clinician uptake grows
3M ago
Rhythm Biosciences’ ColoSTAT Test Gains Early Clinical Traction in Underserved CRC Patients
Premium
Company Announcements
Rhythm Biosciences’ ColoSTAT Test Gains Early Clinical Traction in Underserved CRC Patients
4M ago
Rhythm Biosciences Schedules Investor Webinar to Update on Cancer Diagnostics Progress
Premium
Company Announcements
Rhythm Biosciences Schedules Investor Webinar to Update on Cancer Diagnostics Progress
4M ago
Rhythm Biosciences clarifies ASX query on underwriting agreement and disclosure gaps
PremiumCompany AnnouncementsRhythm Biosciences clarifies ASX query on underwriting agreement and disclosure gaps
4M ago
Rhythm Biosciences Raises $5.5m to Accelerate ColoSTAT and geneType Sales
Premium
Company Announcements
Rhythm Biosciences Raises $5.5m to Accelerate ColoSTAT and geneType Sales
4M ago
Rhythm Biosciences updates market on director’s lapsed unlisted options
Premium
Company Announcements
Rhythm Biosciences updates market on director’s lapsed unlisted options
5M ago
Rhythm Biosciences Seeks ASX Quotation for 2.9 Million New Shares
PremiumCompany AnnouncementsRhythm Biosciences Seeks ASX Quotation for 2.9 Million New Shares
5M ago
Rhythm Biosciences Seeks ASX Quotation for 1.96 Million New Shares
Premium
Company Announcements
Rhythm Biosciences Seeks ASX Quotation for 1.96 Million New Shares
5M ago
Rhythm Biosciences Scales ColoSTAT Rollout via 4Cyte Pathology Network
Premium
Company Announcements
Rhythm Biosciences Scales ColoSTAT Rollout via 4Cyte Pathology Network
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100